Literature DB >> 31377261

Total glucosides of peony improve ovalbumin-induced allergic asthma by inhibiting mast cell degranulation.

Qiyang Shou1, Jiali Lang1, Lu Jin1, Mingsun Fang2, Beibei Cao3, Yueqin Cai2, Zhunan Ni4, Fengmei Qiu5, Changyu Li2, Gang Cao6, Huiying Fu7.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Paeonia lactiflora Pall. (peony) is a medicinal plant used in the Xiaoqinglong decoction, a commonly prescribed traditional Chinese medicine for asthma. The main active ingredients of peony roots-described as the total glucosides of peony (TGP)-have anti-inflammatory, immunomodulatory, and protective effects on endothelial cells, and they are known to improve rheumatoid arthritis. This study explored the underlying mechanism of TGP activity in the treatment of allergic asthma.
MATERIALS AND METHODS: Allergic asthma was induced in BALB/c mice by administering injections of ovalbumin (OVA) mixed with aluminum hydroxide gel and inhaling nebulized OVA. The OVA-sensitized mice were treated with TGP by oral gavage, and the potentially anti-asthmatic treatment effect was studied by testing airway hyperresponsiveness, classifying and counting of leukocytes, performing cytokine assays, and analyzing the lung histopathology. The β-hexosaminidase activity was assayed as a biomarker to evaluate the effect of TGP on mast cell degranulation. The mechanism of TGP was explored by monitoring the Ca2+ influx level in mast cells (RBL-2H3) using a Ca2+ fluorescent probe technique.
RESULTS: In mice with OVA-induced allergic asthma, TGP reduced airway hyperresponsiveness and improved lung tissue pathology, which included a decrease in inflammatory cell infiltration and collagen deposition. TGP also significantly lowered BALF leukocyte, eosinophil, and neutrophil counts, along with chemokines and cytokines, such as eotaxin, TNF-α, IL-4, and MIP-1α, in serum and lungs of OVA-challenged mice. These effects were further confirmed with the decrease of β-hexosaminidase release and the inhibition of Ca2+ influx in mast cell degranulation.
CONCLUSIONS: Our findings suggest that TGP improved OVA-induced allergic asthma in mice mainly by suppressing Ca2+ influx-dependent mast cell degranulation.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Asthma; Immunity; Mast cell; Total glucosides of peony

Mesh:

Substances:

Year:  2019        PMID: 31377261     DOI: 10.1016/j.jep.2019.112136

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways.

Authors:  Chang Xu; Liangchang Li; Chongyang Wang; Jingzhi Jiang; Li Li; Lianhua Zhu; Shan Jin; Zhehu Jin; Jung Joon Lee; Guanhao Li; Guanghai Yan
Journal:  J Ginseng Res       Date:  2021-10-13       Impact factor: 5.735

2.  Network Pharmacology Analysis of the Identification of Phytochemicals and Therapeutic Mechanisms of Paeoniae Radix Alba for the Treatment of Asthma.

Authors:  Jingwei Wang; Ling Peng; Lu Jin; Huiying Fu; Qiyang Shou
Journal:  J Immunol Res       Date:  2021-09-14       Impact factor: 4.818

3.  Canavalia gladiata Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK.

Authors:  Wen Yan Huang; Sang Hoon Lee; Seong Ju Oh; Hyeock Yoon; Jeong Hoon Pan; Inhye Jeong; Mi Jeong Kim; Bok Kyung Han; Jae Kyeom Kim; Eui-Cheol Shin; Young Jun Kim
Journal:  Molecules       Date:  2022-09-25       Impact factor: 4.927

4.  Inhibitory Effects of Gyeji-Tang on MMP-9 Activity and the Expression of Adhesion Molecules in IL-4- and TNF-α-Stimulated BEAS-2B Cells.

Authors:  Yu Jin Kim; Woo-Young Jeon; Youn-Hwan Hwang; Mee-Young Lee
Journal:  Plants (Basel)       Date:  2021-05-10

5.  Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation.

Authors:  Peeraphong Lertnimitphun; Wenhui Zhang; Wenwei Fu; Baican Yang; Changwu Zheng; Man Yuan; Hua Zhou; Xue Zhang; Weizhong Pei; Yue Lu; Hongxi Xu
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.